Pfizer Inc (MIL:1PFE)
€ 25 -0.395 (-1.56%) Market Cap: 140.28 Bil Enterprise Value: 192.77 Bil PE Ratio: 36.11 PB Ratio: 1.64 GF Score: 63/100

Pfizer Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 27, 2021 / 04:10PM GMT
Louise Alesandra Chen
Cantor Fitzgerald & Co., Research Division - Senior Research Analyst & MD

Good day. I'm Louise Chen, the large-cap and biopharma analyst here at Cantor. Before we begin, I wanted to turn the presentation over to Chris Stevo in Investor Relations to make some forward-looking statements.

Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer

Thank you, Louise. Just a quick reminder that we'll be making forward-looking statements and forward-looking commentary as well. And as you're all familiar, actual results could be different than these. Additional information regarding forward-looking statements is available under risk factors and forward-looking information and factors that may affect future results in our SEC filings, on Form 10-K and 10-Q. Thank you.

Louise Alesandra Chen
Cantor Fitzgerald & Co., Research Division - Senior Research Analyst & MD

Thank you very much, Chris. And now I'd like to introduce Albert Bourla, our keynote speaker and the CEO of Pfizer.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot